TotalMarketCap

Karyopharm Therapeutics

KPTINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.397 M

$0.06 -15.50%

Close of 6 Nov 2026

As of 6 Nov 2026, Karyopharm Therapeutics (KPTI) has a market capitalization of $1.40M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$146.1M

#2380 by revenue

Earnings

-$196.0M

Loss-making

Shares outstanding

22,681,460

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #490Kairos PharmaKAPA$1.55M
  2. #491Lakewood-Amedex BiotherapeuticsLABT$1.42M
  3. #492Karyopharm TherapeuticsKPTI$1.40M
  4. #493PMGCELAB$1.32M
  5. #494Biodexa PharmaceuticalsBDRX$1.26M

What if Karyopharm Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,244,932

Per share 20,209,933× higher

Bitcoin $1.53T

$67,361.10

Per share 1,093,524× higher

Apple $5.02T

$221,140.19

Per share 3,589,938× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Karyopharm Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.